Treace Medical Concepts Inc (TMCI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Sales | 50,214 | 47,387 | 52,570 | 68,708 | 45,086 |
| Cost of Goods | 10,508 | 9,635 | 10,677 | 13,231 | 8,954 |
| Gross Profit | 39,706 | 37,752 | 41,893 | 55,477 | 36,132 |
| Operating Expenses | 55,890 | 55,361 | 58,152 | 55,912 | 52,220 |
| Operating Income | -15,676 | -16,974 | -15,582 | -204 | -15,134 |
| Interest Expense | 1,338 | 1,321 | 1,311 | 1,314 | 1,313 |
| Other Income | 726 | 897 | 971 | 1,017 | 1,087 |
| Pre-tax Income | -16,288 | -17,398 | -15,922 | -501 | -15,360 |
| Net Income Continuous | -16,288 | -17,398 | -15,922 | -501 | -15,360 |
| Net Income | $-16,288 | $-17,398 | $-15,922 | $-501 | $-15,360 |
| EPS Basic Total Ops | -0.26 | -0.28 | -0.25 | -0.01 | -0.25 |
| EPS Basic Continuous Ops | -0.26 | -0.28 | -0.25 | -0.01 | -0.25 |
| EPS Diluted Total Ops | -0.26 | -0.28 | -0.25 | -0.01 | -0.25 |
| EPS Diluted Continuous Ops | -0.26 | -0.28 | -0.25 | -0.01 | -0.25 |
| EPS Diluted Before Non-Recurring Items | -0.26 | -0.28 | -0.25 | -0.01 | -0.25 |
| EBITDA(a) | $-12,828 | $-14,361 | $-13,124 | $1,881 | $-13,136 |